Abstract
Peroxisomal single enzyme and transporter deficiencies are inherited human diseases caused by the absence of individual enzymatic activities exerted in peroxisomes. These deficiencies either cause an abnormal accumulation of substances normally degraded in peroxisomes or the lack of biomolecules that require peroxisomal function for their synthesis. Consequently, the symptoms observed in diverse tissues of affected patients can be interpreted as consequences of metabolic intoxications or deficiencies in essential biomolecules. Thus, these detrimental effects should add-up to a very severe pathology upon concomitant inactivation of all peroxisomal functions, which is actually observed in patients suffering from peroxisome biogenesis disorders. Interestingly, only a subset of peroxisomal enzymes has been associated with single enzyme and transporter deficiencies and the inactivation of enzymes participating in the same metabolic pathway sometimes presents with drastically different phenotypical outcomes. Moreover, a remarkable spectrum of clinical pictures has been observed in human patients suffering from the same single enzyme deficiency. The utilization of mice lacking specifically one gene encoding for a peroxisomal enzyme (knockout-mice) allows the reduction of the broad spectrum of pathologies observed in human patients, because these mice are genetically very similar and live under standardized housing conditions. Thereby, these mice can serve as valuable tools to confirm biochemical outcomes of enzyme inactivation, to attribute specific phenotypic aberrations to the absence of an individual enzyme, and to test the contribution of exogenously added compounds to the development of certain symptoms.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- RCDP:
-
Rhizomelic chondrodysplasia punctate
- MRI:
-
Magnetic resonance imaging
- PAF:
-
Platelet activating factor
- PBD:
-
Peroxisome biogenesis disorder
- PUFA:
-
Polyunsaturated fatty acid
- VLCFA:
-
Very long chain fatty acids
References
Agamanolis DP, Novak RW (1995) Rhizomelic chondrodysplasia punctata: report of a case with review of the literature and correlation with other peroxisomal disorders. Pediatr Pathol Lab Med 15(3):503–513
Agrimi G, Russo A, Pierri CL, Palmieri F (2012) The peroxisomal NAD + carrier of Arabidopsis thaliana transports coenzyme A and its derivatives. J Bioenerg Biomembr 44(3):333–340. doi:10.1007/s10863-012-9445-0
Amery L, Fransen M, De Nys K, Mannaerts GP, Van Veldhoven PP (2000) Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. J Lipid Res 41(11):1752–1759
Arnauld S, Fidaleo M, Clemencet MC, Chevillard G, Athias A, Gresti J, Wanders RJ, Latruffe N, Nicolas-Frances V, Mandard S (2009) Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643. Biochimie 91(11–12):1376–1386. doi:10.1016/j.biochi.2009.09.004
Ashibe B, Hirai T, Higashi K, Sekimizu K, Motojima K (2007) Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing. J Biol Chem 282(28):20763–20773. doi:10.1074/jbc.M611853200
Atshaves BP, Payne HR, McIntosh AL, Tichy SE, Russell D, Kier AB, Schroeder F (2004) Sexually dimorphic metabolism of branched-chain lipids in C57BL/6J mice. J Lipid Res 45(5):812–830. doi:10.1194/jlr.M300408-JLR200
Atshaves BP, McIntosh AL, Landrock D, Payne HR, Mackie JT, Maeda N, Ball J, Schroeder F, Kier AB (2007) Effect of SCP-x gene ablation on branched-chain fatty acid metabolism. Am J Physiol Gastrointest Liver Physiol 292(3):G939–G951. doi:10.1152/ajpgi.00308.2006
Baes M, Van Veldhoven PP (2012) Mouse models for peroxisome biogenesis defects and beta-oxidation enzyme deficiencies. Biochim Biophys Acta 1822(9):1489–1500. doi:10.1016/j.bbadis.2012.03.003
Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, Evrard P, Fahimi D, Declercq PE, Collen D, van Veldhoven PP, Mannaerts GP (1997) A mouse model for Zellweger syndrome. Nat Genet 17(1):49–57. doi:10.1038/ng0997-49
Baes M, Huyghe S, Carmeliet P, Declercq PE, Collen D, Mannaerts GP, Van Veldhoven PP (2000) Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids. J Biol Chem 275(21):16329–16336. doi:10.1074/jbc.M001994200
Baes M, Gressens P, Huyghe S, De NK, Qi C, Jia Y, Mannaerts GP, Evrard P, Van VP, Declercq PE, Reddy JK (2002) The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal beta-oxidation. J Neuropathol Exp Neurol 61(4):368–374
Bams-Mengerink AM, Majoie CB, Duran M, Wanders RJ, Van Hove J, Scheurer CD, Barth PG, Poll-The BT (2006) MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata. Neurology 66(6):798–803. doi:10.1212/01.wnl.0000205594.34647.d0, discussion 789
Beckers J, Wurst W, de Angelis MH (2009) Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling. Nat Rev Genet 10(6):371–380. doi:10.1038/nrg2578
Berger J, Gartner J (2006) X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 1763(12):1721–1732. doi:10.1016/j.bbamcr.2006.07.010
Bernhardt K, Wilkinson S, Weber AP, Linka N (2012) A peroxisomal carrier delivers NAD(+) and contributes to optimal fatty acid degradation during storage oil mobilization. Plant J 69(1):1–13. doi:10.1111/j.1365-313X.2011.04775.x
Bösze P, Skripeczky K, Gaál M, Tóth A, László J (1983) Perrault’s syndrome in two sisters. Am J Med Genet 16(2):237–241
Braverman NE, Moser AB (2012) Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 1822(9):1442–1452. doi:10.1016/j.bbadis.2012.05.008
Braverman N, Steel G, Obie C, Moser A, Moser H, Gould SJ, Valle D (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 15(4):369–376
Breidenbach RW, Beevers H (1967) Association of the glyoxylate cycle enzymes in a novel subcellular particle from castor bean endosperm. Biochem Biophys Res Commun 27(4):462–469
Brennemann W, Kohler W, Zierz S, Klingmuller D (1997) Testicular dysfunction in adrenomyeloneuropathy. Eur J Endocrinol 137(1):34–39
Carlton VE, Harris BZ, Puffenberger EG, Batta AK, Knisely AS, Robinson DL, Strauss KA, Shneider BL, Lim WA, Salen G, Morton DH, Bull LN (2003) Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet 34(1):91–96. doi:10.1038/ng1147
Cheng JB, Russell DW (2004) Mammalian wax biosynthesis. I. Identification of two fatty acyl-Coenzyme A reductases with different substrate specificities and tissue distributions. J Biol Chem 279(36):37789–37797. doi:10.1074/jbc.M406225200
Chevillard G, Clemencet MC, Latruffe N, Nicolas-Frances V (2004) Targeted disruption of the peroxisomal thiolase B gene in mouse: a new model to study disorders related to peroxisomal lipid metabolism. Biochimie 86(11):849–856. doi:10.1016/j.biochi.2004.09.028
Clarke CE, Alger S, Preece MA, Burdon MA, Chavda S, Denis S, Ferdinandusse S, Wanders RJ (2004) Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. Neurology 63(1):188–189
Clayton PT, Lake BD, Hjelm M, Stephenson JB, Besley GT, Wanders RJ, Schram AW, Tager JM, Schutgens RB, Lawson AM (1988) Bile acid analyses in “pseudo-Zellweger” syndrome; clues to the defect in peroxisomal beta-oxidation. J Inherit Metab Dis 11(Suppl 2):165–168
Danpure CJ (2004) Molecular aetiology of primary hyperoxaluria type 1. Nephron Exp Nephrol 98(2):e39–e44. doi:10.1159/000080254
Danpure CJ, Jennings PR (1986) Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201(1):20–24
de Launoit Y, Adamski J (1999) Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome. J Mol Endocrinol 22(3):227–240
De Laurenzi V, Rogers GR, Hamrock DJ, Marekov LN, Steinert PM, Compton JG, Markova N, Rizzo WB (1996) Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 12(1):52–57. doi:10.1038/ng0196-52
de Vet EC, Ijlst L, Oostheim W, Wanders RJ, van den Bosch H (1998) Alkyl-dihydroxyacetonephosphate synthase. Fate in peroxisome biogenesis disorders and identification of the point mutation underlying a single enzyme deficiency. J Biol Chem 273(17):10296–10301
Dick D, Horvath R, Chinnery PF (2011) AMACR mutations cause late-onset autosomal recessive cerebellar ataxia. Neurology 76(20):1768–1770. doi:10.1212/WNL.0b013e31821a4484
Dodt G, Kim DG, Reimann SA, Reuber BE, McCabe K, Gould SJ, Mihalik SJ (2000) L-Pipecolic acid oxidase, a human enzyme essential for the degradation of L-pipecolic acid, is most similar to the monomeric sarcosine oxidases. Biochem J 345(Pt 3):487–494
Dommes V, Baumgart C, Kunau WH (1981) Degradation of unsaturated fatty acids in peroxisomes. Existence of a 2,4-dienoyl-CoA reductase pathway. J Biol Chem 256(16):8259–8262
Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW (2005) Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr 146(4):528–532. doi:10.1016/j.jpeds.2004.10.067
El Hajj HI, Vluggens A, Andreoletti P, Ragot K, Mandard S, Kersten S, Waterham HR, Lizard G, Wanders RJ, Reddy JK, Cherkaoui-Malki M (2012) The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy). Endocrinology 153(6):2568–2575. doi:10.1210/en.2012-1137
Engelen M, Schackmann MJ, Ofman R, Sanders RJ, Dijkstra IM, Houten SM, Fourcade S, Pujol A, Poll-The BT, Wanders RJ, Kemp S (2012) Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation. J Inherit Metab Dis 35(6):1137–1145. doi:10.1007/s10545-012-9471-4
Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, Kistowska M, Forss-Petter S, Ni G, Colone A, Singhal A, Berger J, Xia C, Mori L, De Libero G (2012) Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 13(5):474–480. doi:10.1038/ni.2245
Fan CY, Pan J, Chu R, Lee D, Kluckman KD, Usuda N, Singh I, Yeldandi AV, Rao MS, Maeda N, Reddy JK (1996) Targeted disruption of the peroxisomal fatty acyl-CoA oxidase gene: generation of a mouse model of pseudoneonatal adrenoleukodystrophy. Ann N Y Acad Sci 804:530–541
Fan CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK (1998) Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J Biol Chem 273(25):15639–15645
Ferdinandusse S, Mulders J, IJlst L, Denis S, Dacremont G, Waterham HR, Wanders RJ (1999) Molecular cloning and expression of human carnitine octanoyltransferase: evidence for its role in the peroxisomal beta-oxidation of branched-chain fatty acids. Biochem Biophys Res Commun 263(1):213–218. doi:10.1006/bbrc.1999.1340
Ferdinandusse S, Denis S, Clayton PT, Graham A, Rees JE, Allen JT, McLean BN, Brown AY, Vreken P, Waterham HR, Wanders RJ (2000a) Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 24(2):188–191. doi:10.1038/72861
Ferdinandusse S, Denis S, IJlst L, Dacremont G, Waterham HR, Wanders RJ (2000b) Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 41(11):1890–1896
Ferdinandusse S, Denis S, van Berkel E, Dacremont G, Wanders RJ (2000c) Peroxisomal fatty acid oxidation disorders and 58 kDa sterol carrier protein X (SCPx). Activity measurements in liver and fibroblasts using a newly developed method. J Lipid Res 41(3):336–342
Ferdinandusse S, Denis S, Mooijer PA, Zhang Z, Reddy JK, Spector AA, Wanders RJ (2001) Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J Lipid Res 42(12):1987–1995
Ferdinandusse S, Meissner T, Wanders RJ, Mayatepek E (2002a) Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of leukotrienes. Biochem Biophys Res Commun 293(1):269–273. doi:10.1016/S0006-291X(02)00214-0
Ferdinandusse S, Rusch H, van Lint AE, Dacremont G, Wanders RJ, Vreken P (2002b) Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders. J Lipid Res 43(3):438–444
Ferdinandusse S, van Grunsven EG, Oostheim W, Denis S, Hogenhout EM, IJlst L, van Roermund CW, Waterham HR, Goldfischer S, Wanders RJ (2002c) Reinvestigation of peroxisomal 3-ketoacyl-CoA thiolase deficiency: identification of the true defect at the level of d-bifunctional protein. Am J Hum Genet 70(6):1589–1593. doi:10.1086/340970
Ferdinandusse S, Denis S, Van Roermund CW, Wanders RJ, Dacremont G (2004) Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids. J Lipid Res 45(6):1104–1111. doi:10.1194/jlr.M300512-JLR200
Ferdinandusse S, Denis S, Overmars H, Van Eeckhoudt L, Van Veldhoven PP, Duran M, Wanders RJ, Baes M (2005) Developmental changes of bile acid composition and conjugation in L- and D-bifunctional protein single and double knockout mice. J Biol Chem 280(19):18658–18666. doi:10.1074/jbc.M414311200
Ferdinandusse S, Denis S, Mooyer PA, Dekker C, Duran M, Soorani-Lunsing RJ, Boltshauser E, Macaya A, Gartner J, Majoie CB, Barth PG, Wanders RJ, Poll-The BT (2006a) Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ann Neurol 59(1):92–104. doi:10.1002/ana.20702
Ferdinandusse S, Kostopoulos P, Denis S, Rusch H, Overmars H, Dillmann U, Reith W, Haas D, Wanders RJ, Duran M, Marziniak M (2006b) Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am J Hum Genet 78(6):1046–1052. doi:10.1086/503921
Ferdinandusse S, Ylianttila MS, Gloerich J, Koski MK, Oostheim W, Waterham HR, Hiltunen JK, Wanders RJ, Glumoff T (2006c) Mutational spectrum of D-bifunctional protein deficiency and structure-based genotype-phenotype analysis. Am J Hum Genet 78(1):112–124. doi:10.1086/498880
Ferdinandusse S, Denis S, Hogenhout EM, Koster J, van Roermund CW, IJlst L, Moser AB, Wanders RJ, Waterham HR (2007) Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat 28(9):904–912. doi:10.1002/humu.20535
Ferdinandusse S, Zomer AW, Komen JC, van den Brink CE, Thanos M, Hamers FP, Wanders RJ, van der Saag PT, Poll-The BT, Brites P (2008) Ataxia with loss of Purkinje cells in a mouse model for Refsum disease. Proc Natl Acad Sci USA 105(46):17712–17717. doi:10.1073/pnas.0806066105
Ferdinandusse S, Barker S, Lachlan K, Duran M, Waterham HR, Wanders RJ, Hammans S (2010) Adult peroxisomal acyl-coenzyme A oxidase deficiency with cerebellar and brainstem atrophy. J Neurol Neurosurg Psychiatry 81(3):310–312. doi:10.1136/jnnp.2009.176255
Ferrer I, Kapfhammer JP, Hindelang C, Kemp S, Troffer-Charlier N, Broccoli V, Callyzot N, Mooyer P, Selhorst J, Vreken P, Wanders RJ, Mandel JL, Pujol A (2005) Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Hum Mol Genet 14(23):3565–3577. doi:10.1093/hmg/ddi384
Fidaleo M, Arnauld S, Clemencet MC, Chevillard G, Royer MC, De Bruycker M, Wanders RJ, Athias A, Gresti J, Clouet P, Degrace P, Kersten S, Espeel M, Latruffe N, Nicolas-Frances V, Mandard S (2011) A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARalpha-mediated upregulation of SREBP-2 target genes in the liver. Biochimie 93(5):876–891. doi:10.1016/j.biochi.2011.02.001
Filppula SA, Yagi AI, Kilpelainen SH, Novikov D, FitzPatrick DR, Vihinen M, Valle D, Hiltunen JK (1998) Delta3,5-delta2,4-dienoyl-CoA isomerase from rat liver. Molecular characterization. J Biol Chem 273(1):349–355
Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave KA (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50(5):829–843
Foulon V, Antonenkov VD, Croes K, Waelkens E, Mannaerts GP, Van Veldhoven PP, Casteels M (1999) Purification, molecular cloning, and expression of 2-hydroxyphytanoyl-CoA lyase, a peroxisomal thiamine pyrophosphate-dependent enzyme that catalyzes the carbon-carbon bond cleavage during alpha-oxidation of 3-methyl-branched fatty acids. Proc Natl Acad Sci USA 96(18):10039–10044
Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A, Jove M, Kemp S, Villarroya F, Ferrer I, Pamplona R, Portero-Otin M, Pujol A (2008) Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 17(12):1762–1773. doi:10.1093/hmg/ddn085
Geisbrecht BV, Zhang D, Schulz H, Gould SJ (1999) Characterization of PECI, a novel monofunctional Delta(3), Delta(2)-enoyl-CoA isomerase of mammalian peroxisomes. J Biol Chem 274(31):21797–21803
Glaser PE, Gross RW (1995) Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms. Biochemistry 34(38):12193–12203
Gloerich J, Ruiter JP, van den Brink DM, Ofman R, Ferdinandusse S, Wanders RJ (2006) Peroxisomal trans-2-enoyl-CoA reductase is involved in phytol degradation. FEBS Lett 580(8):2092–2096. doi:10.1016/j.febslet.2006.03.011
Goth L, Rass P, Pay A (2004) Catalase enzyme mutations and their association with diseases. Mol Diagn 8(3):141–149
Gronemeyer T, Wiese S, Ofman R, Bunse C, Pawlas M, Hayen H, Eisenacher M, Stephan C, Meyer HE, Waterham HR, Erdmann R, Wanders RJ, Warscheid B (2013) The proteome of human liver peroxisomes: identification of five new peroxisomal constituents by a label-free quantitative proteomics survey. PLoS One 8(2):e57395. doi:10.1371/journal.pone.0057395
Hajra AK (1997) Dihydroxyacetone phosphate acyltransferase. Biochim Biophys Acta 1348(1–2):27–34
Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, Yeldandi AV, Rao MS, Reddy JK (1999) Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 274(27):19228–19236
Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS (2000) Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 275(37):28918–28928. doi:10.1074/jbc.M910350199
Haugarvoll K, Johansson S, Tzoulis C, Haukanes BI, Bredrup C, Neckelmann G, Boman H, Knappskog PM, Bindoff LA (2013) MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing. Orphanet J Rare Dis 8:1. doi:10.1186/1750-1172-8-1
Ho YS, Xiong Y, Ma W, Spector A, Ho DS (2004) Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279(31):32804–32812. doi:10.1074/jbc.M404800200
Hoppe B (2012) An update on primary hyperoxaluria. Nat Rev Nephrol 8(8):467–475. doi:10.1038/nrneph.2012.113
Houten SM, Denis S, Argmann CA, Jia Y, Ferdinandusse S, Reddy JK, Wanders RJ (2012) Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids. J Lipid Res 53(7):1296–1303. doi:10.1194/jlr.M024463
Huang J, Viswakarma N, Yu S, Jia Y, Bai L, Vluggens A, Cherkaoui-Malki M, Khan M, Singh I, Yang G, Rao MS, Borensztajn J, Reddy JK (2011) Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol 179(2):703–713. doi:10.1016/j.ajpath.2011.04.030
Huang J, Jia Y, Fu T, Viswakarma N, Bai L, Rao MS, Zhu Y, Borensztajn J, Reddy JK (2012) Sustained activation of PPARalpha by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J 26(2):628–638. doi:10.1096/fj.11-194019
Huffnagel IC, Clur SA, Bams-Mengerink AM, Blom NA, Wanders RJ, Waterham HR, Poll-The BT (2013) Rhizomelic chondrodysplasia punctata and cardiac pathology. J Med Genet 50(7):419–424. doi:10.1136/jmedgenet-2013-101536
Hungerbuhler JP, Meier C, Rousselle L, Quadri P, Bogousslavsky J (1985) Refsum’s disease: management by diet and plasmapheresis. Eur Neurol 24(3):153–159
Huyghe S, Casteels M, Janssen A, Meulders L, Mannaerts GP, Declercq PE, Van Veldhoven PP, Baes M (2001) Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse. Biochem J 353(Pt 3):673–680
Huyghe S, Schmalbruch H, De Gendt K, Verhoeven G, Guillou F, Van Veldhoven PP, Baes M (2006a) Peroxisomal multifunctional protein 2 is essential for lipid homeostasis in Sertoli cells and male fertility in mice. Endocrinology 147(5):2228–2236. doi:10.1210/en.2005-1571
Huyghe S, Schmalbruch H, Hulshagen L, Veldhoven PV, Baes M, Hartmann D (2006b) Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system. Am J Pathol 168(4):1321–1334. doi:10.2353/ajpath.2006.041220
Hwang I, Lee J, Huh JY, Park J, Lee HB, Ho YS, Ha H (2012) Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61(3):728–738. doi:10.2337/db11-0584
Ijlst L, de Kromme I, Oostheim W, Wanders RJ (2000) Molecular cloning and expression of human L-pipecolate oxidase. Biochem Biophys Res Commun 270(3):1101–1105. doi:10.1006/bbrc.2000.2575
Jansen GA, Wanders RJ, Watkins PA, Mihalik SJ (1997) Phytanoyl-coenzyme A hydroxylase deficiency—the enzyme defect in Refsum‘s disease. N Engl J Med 337(2):133–134. doi:10.1056/NEJM199707103370215
Jansen GA, van den Brink DM, Ofman R, Draghici O, Dacremont G, Wanders RJ (2001) Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes. Biochem Biophys Res Commun 283(3):674–679. doi:10.1006/bbrc.2001.4835
Jansen GA, Waterham HR, Wanders RJ (2004) Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7). Hum Mutat 23(3):209–218. doi:10.1002/humu.10315
Jia Y, Qi C, Zhang Z, Hashimoto T, Rao MS, Huyghe S, Suzuki Y, Van Veldhoven PP, Baes M, Reddy JK (2003) Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system. J Biol Chem 278(47):47232–47239. doi:10.1074/jbc.M306363200
Johnson MR, Barnes S, Kwakye JB, Diasio RB (1991) Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from human liver. J Biol Chem 266(16):10227–10233
Jones JM, Morrell JC, Gould SJ (2000) Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J Biol Chem 275(17):12590–12597
Kanzawa N, Maeda Y, Ogiso H, Murakami Y, Taguchi R, Kinoshita T (2009) Peroxisome dependency of alkyl-containing GPI-anchor biosynthesis in the endoplasmic reticulum. Proc Natl Acad Sci USA 106(42):17711–17716. doi:10.1073/pnas.0904762106
Kapina V, Sedel F, Truffert A, Horvath J, Wanders RJ, Waterham HR, Picard F (2010) Relapsing rhabdomyolysis due to peroxisomal alpha-methylacyl-coa racemase deficiency. Neurology 75(14):1300–1302. doi:10.1212/WNL.0b013e3181f612a5
Kisaki T, Tolbert NE (1969) Glycolate and glyoxylate metabolism by isolated peroxisomes or chloroplasts. Plant Physiol 44(2):242–250
Knight J, Jiang J, Assimos DG, Holmes RP (2006) Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70(11):1929–1934. doi:10.1038/sj.ki.5001906
Knight J, Holmes RP, Cramer SD, Takayama T, Salido E (2012) Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol 302(6):F688–F693. doi:10.1152/ajprenal.00473.2011
Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232(3):631–636. doi:10.1006/bbrc.1997.6340
Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, Makino H (2005) Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 68(3):1018–1031. doi:10.1111/j.1523-1755.2005.00494.x
Kodama S, Nishio H, Nakajima T, Nakamura H (1990) Urinary dicarboxylic acids in X-linked adrenoleukodystrophy. Acta Paediatr Jpn 32(3):257–261, Overseas edition
Komljenovic D, Sandhoff R, Teigler A, Heid H, Just WW, Gorgas K (2009) Disruption of blood-testis barrier dynamics in ether-lipid-deficient mice. Cell Tissue Res 337(2):281–299. doi:10.1007/s00441-009-0809-7
Kotti TJ, Savolainen K, Helander HM, Yagi A, Novikov DK, Kalkkinen N, Conzelmann E, Hiltunen JK, Schmitz W (2000) In mouse alpha -methylacyl-CoA racemase, the same gene product is simultaneously located in mitochondria and peroxisomes. J Biol Chem 275(27):20887–20895. doi:10.1074/jbc.M002067200
Krysko O, Bottelbergs A, Van Veldhoven P, Baes M (2010) Combined deficiency of peroxisomal beta-oxidation and ether lipid synthesis in mice causes only minor cortical neuronal migration defects but severe hypotonia. Mol Genet Metab 100(1):71–76. doi:10.1016/j.ymgme.2010.02.003
Leumann E, Hoppe B (2001) The primary hyperoxalurias. J Am Soc Nephrol 12(9):1986–1993
Liegel R, Chang B, Dubielzig R, Sidjanin DJ (2011) Blind sterile 2 (bs2), a hypomorphic mutation in Agps, results in cataracts and male sterility in mice. Mol Genet Metab 103(1):51–59. doi:10.1016/j.ymgme.2011.02.002
Lopez-Erauskin J, Fourcade S, Galino J, Ruiz M, Schluter A, Naudi A, Jove M, Portero-Otin M, Pamplona R, Ferrer I, Pujol A (2011) Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol 70(1):84–92. doi:10.1002/ana.22363
Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 94(17):9366–9371
Martens K, Loren V, van Themaat E, van Batenburg MF, Heinaniemi M, Huyghe S, Van Hummelen P, Carlberg C, Van Veldhoven PP, Van Kampen A, Baes M (2008) Coordinate induction of PPAR alpha and SREBP2 in multifunctional protein 2 deficient mice. Biochim Biophys Acta 1781(11–12):694–702. doi:10.1016/j.bbalip.2008.07.010
Mihalik SJ, Moser HW, Watkins PA, Danks DM, Poulos A, Rhead WJ (1989) Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients. Pediatr Res 25(5):548–552. doi:10.1203/00006450-198905000-00024
Mihalik SJ, Rainville AM, Watkins PA (1995) Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors. Eur J Biochem 232(2):545–551
Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ (1997) Identification of PAHX, a Refsum disease gene. Nat Genet 17(2):185–189. doi:10.1038/ng1097-185
Mitchell J, Paul P, Chen HJ, Morris A, Payling M, Falchi M, Habgood J, Panoutsou S, Winkler S, Tisato V, Hajitou A, Smith B, Vance C, Shaw C, Mazarakis ND, de Belleroche J (2010) Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci USA 107(16):7556–7561. doi:10.1073/pnas.0914128107
Mizumoto H, Akashi R, Hikita N, Kumakura A, Yoshida Y, Honda A, Shimozawa N, Hata D (2012) Mild case of D-bifunctional protein deficiency associated with novel gene mutations. Pediatr Int 54(2):303–304. doi:10.1111/j.1442-200X.2012.03562.x
Morita M, Imanaka T (2012) Peroxisomal ABC transporters: structure, function and role in disease. Biochim Biophys Acta 1822(9):1387–1396. doi:10.1016/j.bbadis.2012.02.009
Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361(6414):726–730. doi:10.1038/361726a0
Netik A, Forss-Petter S, Holzinger A, Molzer B, Unterrainer G, Berger J (1999) Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum Mol Genet 8(5):907–913
Nguyen SD, Baes M, Van Veldhoven PP (2008) Degradation of very long chain dicarboxylic polyunsaturated fatty acids in mouse hepatocytes, a peroxisomal process. Biochim Biophys Acta 1781(8):400–405. doi:10.1016/j.bbalip.2008.06.004
Ofman R, Hettema EH, Hogenhout EM, Caruso U, Muijsers AO, Wanders RJ (1998) Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum Mol Genet 7(5):847–853
Ogata M (1991) Acatalasemia. Hum Genet 86(4):331–340
Ohide H, Miyoshi Y, Maruyama R, Hamase K, Konno R (2011) D-Amino acid metabolism in mammals: biosynthesis, degradation and analytical aspects of the metabolic study. J Chromatogr B Anal Technol Biomed Life Sci 879(29):3162–3168. doi:10.1016/j.jchromb.2011.06.028
Oliet SH, Mothet JP (2009) Regulation of N-methyl-D-aspartate receptors by astrocytic D-serine. Neuroscience 158(1):275–283. doi:10.1016/j.neuroscience.2008.01.071
Perrault M, Klotz B, Housset E (1951) Deux cas de syndrome de Turner avec surdi-mutite dans une meme fratrie. Bull Mem Soc Med Hop Paris 16:79–84, http://www.ncbi.nlm.nih.gov/pubmed/6650568
Pierce SB, Walsh T, Chisholm KM, Lee MK, Thornton AM, Fiumara A, Opitz JM, Levy-Lahad E, Klevit RE, King MC (2010) Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome. Am J Hum Genet 87(2):282–288. doi:10.1016/j.ajhg.2010.07.007
Pike LJ, Han X, Chung KN, Gross RW (2002) Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41(6):2075–2088
Poll-The BT, Gartner J (2012) Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders. Biochim Biophys Acta 1822(9):1421–1429. doi:10.1016/j.bbadis.2012.03.011
Poll-The BT, Roels F, Ogier H, Scotto J, Vamecq J, Schutgens RB, Wanders RJ, van Roermund CW, van Wijland MJ, Schram AW et al (1988) A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet 42(3):422–434
Powers JM, Kenjarski TP, Moser AB, Moser HW (1999) Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells. Acta Neuropathol 98(2):129–134
Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW (2000) Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 59(2):89–102
Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL (2002) Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11(5):499–505
Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C, Callizot N, Ruiz M, Pampols T, Giros M, Mandel JL (2004) Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 13(23):2997–3006. doi:10.1093/hmg/ddh323
Qi C, Zhu Y, Pan J, Usuda N, Maeda N, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK (1999) Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism. J Biol Chem 274(22):15775–15780
Rizzo C, Boenzi S, Wanders RJ, Duran M, Caruso U, Dionisi-Vici C (2003) Characteristic acylcarnitine profiles in inherited defects of peroxisome biogenesis: a novel tool for screening diagnosis using tandem mass spectrometry. Pediatr Res 53(6):1013–1018
Rodemer C, Thai TP, Brugger B, Kaercher T, Werner H, Nave KA, Wieland F, Gorgas K, Just WW (2003) Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum Mol Genet 12(15):1881–1895
Rokka A, Antonenkov VD, Soininen R, Immonen HL, Pirila PL, Bergmann U, Sormunen RT, Weckstrom M, Benz R, Hiltunen JK (2009) Pxmp2 is a channel-forming protein in Mammalian peroxisomal membrane. PLoS One 4(4):e5090. doi:10.1371/journal.pone.0005090
Ruether K, Baldwin E, Casteels M, Feher MD, Horn M, Kuranoff S, Leroy BP, Wanders RJ, Wierzbicki AS (2010) Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy. Surv Ophthalmol 55(6):531–538. doi:10.1016/j.survophthal.2010.03.007
Salido EC, Li XM, Lu Y, Wang X, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdhury J (2006) Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. Proc Natl Acad Sci USA 103(48):18249–18254. doi:10.1073/pnas.0607218103
Salido E, Pey AL, Rodriguez R, Lorenzo V (2012) Primary hyperoxalurias: disorders of glyoxylate detoxification. Biochim Biophys Acta 1822(9):1453–1464. doi:10.1016/j.bbadis.2012.03.004
Sasabe J, Chiba T, Yamada M, Okamoto K, Nishimoto I, Matsuoka M, Aiso S (2007) D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J 26(18):4149–4159. doi:10.1038/sj.emboj.7601840
Sasabe J, Miyoshi Y, Suzuki M, Mita M, Konno R, Matsuoka M, Hamase K, Aiso S (2012) D-amino acid oxidase controls motoneuron degeneration through D-serine. Proc Natl Acad Sci USA 109(2):627–632. doi:10.1073/pnas.1114639109
Savolainen K, Kotti TJ, Schmitz W, Savolainen TI, Sormunen RT, Ilves M, Vainio SJ, Conzelmann E, Hiltunen JK (2004) A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids. Hum Mol Genet 13(9):955–965. doi:10.1093/hmg/ddh107
Schram AW, Goldfischer S, van Roermund CW, Brouwer-Kelder EM, Collins J, Hashimoto T, Heymans HS, van den Bosch H, Schutgens RB, Tager JM et al (1987) Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci USA 84(8):2494–2496
Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T, Denis S, Wouters F, Wirtz KW, Wanders RJ, Maeda N, Assmann G (1998) Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev 12(8):1189–1201
Selkala EM, Kuusisto SM, Salonurmi T, Savolainen MJ, Jauhiainen M, Pirila PL, Kvist AP, Conzelmann E, Schmitz W, Alexson SE, Kotti TJ, Hiltunen JK, Autio KJ (2013) Metabolic adaptation allows Amacr-deficient mice to remain symptom-free despite low levels of mature bile acids. Biochim Biophys Acta 1831(8):1335–1343. doi:10.1016/j.bbalip.2013.05.002
Setchell KD, Heubi JE, Shah S, Lavine JE, Suskind D, Al-Edreesi M, Potter C, Russell DW, O’Connell NC, Wolfe B, Jha P, Zhang W, Bove KE, Knisely AS, Hofmann AF, Rosenthal P, Bull LN (2013) Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology 144(5):945–955 e946; quiz e914–945. doi:10.1053/j.gastro.2013.02.004
Smith EH, Gavrilov DK, Oglesbee D, Freeman WD, Vavra MW, Matern D, Tortorelli S (2010) An adult onset case of alpha-methyl-acyl-CoA racemase deficiency. J Inherit Metab Dis 33(Suppl 3):S349–S353. doi:10.1007/s10545-010-9183-6
Suzuki Y, Jiang LL, Souri M, Miyazawa S, Fukuda S, Zhang Z, Une M, Shimozawa N, Kondo N, Orii T, Hashimoto T (1997) D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder. Am J Hum Genet 61(5):1153–1162. doi:10.1086/301599
Sztriha L, Al-Gazali LI, Wanders RJ, Ofman R, Nork M, Lestringant GG (2000) Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency). Dev Med Child Neurol 42(7):492–495
Takahara S (1952) Progressive oral gangrene probably due to lack of catalase in the blood (acatalasaemia); report of nine cases. Lancet 2(6745):1101–1104
Teigler A, Komljenovic D, Draguhn A, Gorgas K, Just WW (2009) Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum. Hum Mol Genet 18(11):1897–1908. doi:10.1093/hmg/ddp110
ten Brink HJ, Wanders RJ, Stellaard F, Schutgens RB, Jakobs C (1991) Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency. J Inherit Metab Dis 14(3):345–348
Thompson SA, Calvin J, Hogg S, Ferdinandusse S, Wanders RJ, Barker RA (2009) Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency. BMJ Case Rep 2009. doi:10.1136/bcr.08.2008.0814
Une M, Konishi M, Suzuki Y, Akaboshi S, Yoshii M, Kuramoto T, Fujimura K (1997) Bile acid profiles in a peroxisomal D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency. J Biochem 122(3):655–658
van den Bosch H, de Vet EC (1997) Alkyl-dihydroxyacetonephosphate synthase. Biochim Biophys Acta 1348(1–2):35–44
van den Brink DM, Wanders RJ (2006) Phytanic acid: production from phytol, its breakdown and role in human disease. Cell Mol Life Sci 63(15):1752–1765. doi:10.1007/s00018-005-5463-y
van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49(2):186–194
van Roermund CW, Visser WF, Ijlst L, Waterham HR, Wanders RJ (2011) Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid beta-oxidation. Biochim Biophys Acta 1811(3):148–152. doi:10.1016/j.bbalip.2010.11.010
Van Veldhoven PP (2010) Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 51(10):2863–2895. doi:10.1194/jlr.R005959
Verheijden S, Bottelbergs A, Krysko O, Krysko DV, Beckers L, De Munter S, Van Veldhoven PP, Wyns S, Kulik W, Nave KA, Ramer MS, Carmeliet P, Kassmann CM, Baes M (2013) Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation. Neurobiol Dis 58C:258–269. doi:10.1016/j.nbd.2013.06.006
Verhoeven NM, Jakobs C, Carney G, Somers MP, Wanders RJ, Rizzo WB (1998a) Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid. FEBS Lett 429(3):225–228
Verhoeven NM, Wanders RJ, Poll-The BT, Saudubray JM, Jakobs C (1998b) The metabolism of phytanic acid and pristanic acid in man: a review. J Inherit Metab Dis 21(7):697–728
Wanders RJ, Waterham HR (2006a) Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 75:295–332. doi:10.1146/annurev.biochem.74.082803.133329
Wanders RJ, Waterham HR (2006b) Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochim Biophys Acta 1763(12):1707–1720. doi:10.1016/j.bbamcr.2006.08.010
Wanders RJ, Romeyn GJ, van Roermund CW, Schutgens RB, van den Bosch H, Tager JM (1988) Identification of L-pipecolate oxidase in human liver and its deficiency in the Zellweger syndrome. Biochem Biophys Res Commun 154(1):33–38
Wanders RJ, Denis S, van Berkel E, Wouters F, Wirtz KW, Seedorf U (1998) Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders. J Inherit Metab Dis 21(3):302–305
Wanders RJ, Komen J, Ferdinandusse S (2011) Phytanic acid metabolism in health and disease. Biochim Biophys Acta 1811(9):498–507. doi:10.1016/j.bbalip.2011.06.006
Waterham HR, Ebberink MS (2012) Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 1822(9):1430–1441. doi:10.1016/j.bbadis.2012.04.006
Weinhofer I, Forss-Petter S, Kunze M, Zigman M, Berger J (2005) X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism. FEBS Lett 579(25):5512–5516. doi:10.1016/j.febslet.2005.09.014
Westin MA, Hunt MC, Alexson SE (2005) The identification of a succinyl-CoA thioesterase suggests a novel pathway for succinate production in peroxisomes. J Biol Chem 280(46):38125–38132. doi:10.1074/jbc.M508479200
Westin MA, Hunt MC, Alexson SE (2008) Short- and medium-chain carnitine acyltransferases and acyl-CoA thioesterases in mouse provide complementary systems for transport of beta-oxidation products out of peroxisomes. Cell Mol Life Sci 65(6):982–990. doi:10.1007/s00018-008-7576-6
Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B (2012) Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat 97(3–4):73–82. doi:10.1016/j.prostaglandins.2012.01.005
White AL, Modaff P, Holland-Morris F, Pauli RM (2003) Natural history of rhizomelic chondrodysplasia punctata. Am J Med Genet A 118A(4):332–342. doi:10.1002/ajmg.a.20009
Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD, Gibberd FB (2002) Refsum’s disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem 80(5):727–735
Wiese S, Gronemeyer T, Ofman R, Kunze M, Grou CP, Almeida JA, Eisenacher M, Stephan C, Hayen H, Schollenberger L, Korosec T, Waterham HR, Schliebs W, Erdmann R, Berger J, Meyer HE, Just W, Azevedo JE, Wanders RJ, Warscheid B (2007) Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. Mol Cell Proteomics 6(12):2045–2057. doi:10.1074/mcp.M700169-MCP200
Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J (2013) Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem 288(26):19269–19279. doi:10.1074/jbc.M112.445445
Willemsen MA, IJlst L, Steijlen PM, Rotteveel JJ, de Jong JG, van Domburg PH, Mayatepek E, Gabreels FJ, Wanders RJ (2001) Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjogren-Larsson syndrome. Brain 124(Pt 7):1426–1437
Acknowledgment
The authors thank Fabian Dorninger, Sonja Forss-Petter, and Christoph Wiesinger for helpful discussions and critically reading the manuscript and Christoph Wiesinger to provide Fig. 8.1.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Wien
About this chapter
Cite this chapter
Kunze, M., Berger, J. (2014). Single Peroxisomal Enzyme and Transporter Deficiencies in Human Diseases and Mouse Models. In: Brocard, C., Hartig, A. (eds) Molecular Machines Involved in Peroxisome Biogenesis and Maintenance. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1788-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1788-0_8
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1787-3
Online ISBN: 978-3-7091-1788-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)